Mayo Clinic

Monoclonal Gammopathy of Thrombotic Significance

ABSTRACT Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic premalignant precursor to multiple myeloma (MM). While development of end‐organ damage in MM largely reflects increasing clonal burden, emerging evidence indicates that qualitative properties of...

Moral emotion processing in euthymic bipolar disorder: insights from network analysis

Abstract Background Bipolar disorder (BD) is associated with facial emotion recognition (FER) deficits. Among these, impairments in recognizing moral emotions may be especially relevant to social dysfunction, but their relationship with brain structure remains poorly defined. Met...

Sequential FIB-4–based testing limits detection of fibrotic MASLD despite optimized ELF thresholds

Background: Societal guidance recommends sequential noninvasive testing for metabolic dysfunction–associated steatotic liver disease (MASLD), using Fibrosis-4 (FIB-4) ≥1.3 as a gatekeeper before second-line assessment with the Enhanced Liver Fibrosis (ELF) score (<7.7 as a rul...

Pediatric Metabolic Syndrome Through the Lens of Cardiovascular-Kidney-Metabolic Syndrome: A Scoping Review of Definitions, Epidemiology, Outcomes, and Conceptual Implications for Children and Adolescents

Abstract Purpose of Review The pediatric metabolic syndrome (MetS) construct lacks an accepted definition, with frameworks yielding prevalence estimates that vary by an order of magnitude within the same populations. In 2023, the American Heart Association introduced cardiovascul...

Effect of time to palliative epilepsy surgery on outcomes

Abstract Objective Epilepsy duration is a modifiable risk factor in the outcome of definitive epilepsy surgery; however, an analogous effect in palliative procedures has not been shown. We reviewed the Pediatric Epilepsy Surgery Database data for an association between epilepsy d...

TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo

TRAIL is a TNF family ligand that trimerizes TRAIL-R1 (DR4) or TRAIL-R2 (DR5) to induce apoptosis, necroptosis, and/or NF-κB activation in receptor-bearing cells. We previously identified TRAILshort as a splice variant of TRAIL that lacks cysteine 230, cannot trimerize, and acts...